Nuwellis, Inc. (NUWE) |
|
2.75 0.1 (3.77%)
|
06-01 15:59 |
|
Open: |
2.66 |
Pre. Close: |
2.65 |
|
High:
|
2.8999 |
Low:
|
2.5711 |
|
Volume:
|
41,613 |
Market Cap:
|
3(M) |
|
|
|
Technical analysis |
as of: 2023-06-01 4:45:53 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 5.27 One year: 6.69 |
| Support: |
Support1: 2.55 Support2: 2.12 |
| Resistance: |
Resistance1: 4.51 Resistance2: 5.73 |
| Pivot: |
2.9  |
| Moving Average: |
MA(5): 2.84 MA(20): 3.16
MA(100): 5.71 MA(250): 29.68 |
| MACD: |
MACD(12,26): -0.5  Signal(9): -0.5 |
| Stochastic oscillator: |
%K(14,3): 16 %D(3): 14.1 |
| RSI: |
RSI(14): 34.1 |
| 52-week: |
High: 185 Low: 2.55 |
| Average Vol(K): |
3-Month: 83 (K) 10-Days: 69 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NUWE ] has closed above bottom band by 21.4%. Bollinger Bands are 79.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.9 - 2.92 |
2.92 - 2.94 |
|
Low:
|
2.53 - 2.55 |
2.55 - 2.57 |
|
Close:
|
2.72 - 2.75 |
2.75 - 2.78 |
|
Company Description |
|
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. |
Headline News |
Tue, 23 May 2023
Nuwellis, Inc. Reports Inducem - GuruFocus.com
Tue, 16 May 2023
Is Nuwellis Inc (NUWE) Stock a Good Value Tuesday? - InvestorsObserver
Tue, 09 May 2023
Healthcare Stocks Moving Tuesday: LGVN, VYGR, YMAB, NVAX, TRVN, ENTA, CHRS, NUWE - InvestorsObserver
Tue, 09 May 2023
Nuwellis, Inc. Announces First Quarter 2023 Financial Results - Yahoo Finance
Tue, 18 Apr 2023
Nuwellis, Inc. To Announce First Quarter 2023 Financial Results on May 9, 2023 - Yahoo Finance
Mon, 17 Apr 2023
Does Nuwellis Inc (NUWE) Have What it Takes to be in Your Portfolio Monday? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
1 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0.4 (%) |
|
% Held by Institutions
|
1.7 (%) |
|
Shares Short
|
33 (K) |
|
Shares Short P.Month
|
31 (K) |
Stock Financials |
|
EPS
|
-48.6 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
23.04 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
3.92 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-0.06 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.11 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
